To include your compound in the COVID-19 Resource Center, submit it here.
On Sept. 18, LifeMine Therapeutics Inc. (Cambridge, Mass.) raised $55 million in a series A round
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury